Myomo, Inc. (MYO) is a Medical - Devices company in the Healthcare sector, currently trading at $0.78. It has a SharesGrow Score of 54/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
Analyst consensus target is MYO = $1 (+40.6% upside).
Valuation: MYO trades at a trailing Price-to-Earnings (P/E) of -1.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.07.
Financials: revenue is $41M, +39.5%/yr average growth. Net income is $16M (loss), growing at +62%/yr. Net profit margin is -38.1% (negative). Gross margin is 65.7% (-0.2 pp trend).
Balance sheet: total debt is $19M against $11M equity (Debt-to-Equity (D/E) ratio 1.7, leveraged). Current ratio is 3.3 (strong liquidity). Debt-to-assets is 50.2%. Total assets: $39M.
Analyst outlook: 7 / 8 analysts rate MYO as buy (88%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 97/100 (Pass), Growth 100/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 46/100 (Partial), Future 94/100 (Pass), Income 10/100 (Fail).
